We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Blood Stem Cell May Help Repair Bone

By Biotechdaily staff writers
Posted on 25 Aug 2004
A single type of primitive stem cell, transplanted from donor mice, gave rise to both blood-forming and bone-forming cells in recipient mice, suggesting that it may someday be the basis of new medical treatments to replace or repair bone lost to disease or injury.

Researchers used a technique called retroviral insertion site analysis to determine which type of bone marrow cell from mice could give rise to bone-producing cells when transplanted into recipient mice. More...
In this technique, researchers add a piece of DNA marked with a green fluorescent protein to bone marrow cells taken from donor mice. The added DNA inserts itself randomly into one of the chromosomes and is duplicated each time the cell replicates. The daughter cells of the originally marked cell were identified by locating the marker in the same site of the chromosome in each succeeding generation.

Using this technique, the researchers at St. Jude Children's Research Hospital (Memphis, TN, USA) followed the fates of the cells removed from donor mice and transplanted into recipient mice whose own marrow cells had been destroyed by radiation. The cells identified in this study seem to be better able to engraft in bone than other bone marrow cells called mesenchymal cells. However, the osteoblasts that arose from donor cells were detectable for only several months in recipient mice, as occurs in human bone marrow transplant patients.

This suggests that repair and regeneration during the first few months after transplantation is driven by the transplanted donor cells that engraft in bones of the recipient. However, long-term maintenance of bone strength may be primarily controlled by other cells already present in the recipient's bone. The results of the research were reported in the August 10, 2004, issue of the Proceedings of the [U.S.] National Academy of Sciences.

"Our findings in mice coupled with previous experience with bone marrow transplantation in humans suggest that we have identified primitive cells in mice that are responsible for bone repair and regeneration,” said senior author Edwin Horwitz, M.D., Ph.D., associate member of the department of hematology/oncology at St. Jude.




Related Links:
St. Jude Med. Ctr

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Automatic Western Blot Analyzer
Tenfly Phoenix Blot Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.